Clinical Trial Update: A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial of ATI-50002 topical solution for alopecia areata was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• ATI-50002 (ATI-50002)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Alopecia Areata | Phase 2 | Status: TERMINATED | Results posted: 2020-06-05